Is there a patient preference component that is a significant driver to helping select agents for multimodal therapy? And what about expectations as part of the ERAS pathway?

Is there a patient preference component that is a significant driver to helping select agents for multimodal therapy? And what about expectations as part of the ERAS pathway?

Is there a patient preference component that is a significant driver to helping select agents for multimodal therapy? And what about expectations as part of the ERAS pathway?


Created by

CMEducation Resources IQ&A Interactive Intelligence Zone

Presenter

Eugene Viscusi, MD

Eugene Viscusi, MD

Associate Professor
Director, Acute Pain Management Service
Department of Anesthesiology
Thomas Jefferson University
Philadelphia, Pennsylvania